With a turnover of $600+Mn, the South Korean leading pharmaceuticals company approached Freyr for the submission of one-time marketing status update to the USFDA (Food and Drug Administration). With few challenges to work upon Freyr was successful in preparing and submitting package well in advance.
How did Freyr carry out the entire process? Read the case to know more.